Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

UPB

Live52w low +10.8%

Core line items from UPB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: UPSTREAM BIO, INC.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31
Revenue	$2.85M	$2.37M	$2.38M
Operating Income	$-160.36M	$-77.76M	$-40.11M
Net Income	$-143.44M	$-62.81M	$-20.54M
EPS (Diluted)	$-2.66	$-5.58	$-12.95
Total Assets	$353.77M	$481.72M	$117.20M
Total Liabilities	$14.00M	$11.87M	$9.39M
Cash & Equivalents	$101.58M	$325.89M	$25.83M
Free Cash Flow OCF − CapEx	$-133.44M	$-59.68M	$-38.07M
Shares Outstanding	54.24M	53.60M	2.99M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from UPB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +10.8%

Entity: UPSTREAM BIO, INC.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31
Revenue	$2.85M	$2.37M	$2.38M
Operating Income	$-160.36M	$-77.76M	$-40.11M
Net Income	$-143.44M	$-62.81M	$-20.54M
EPS (Diluted)	$-2.66	$-5.58	$-12.95
Total Assets	$353.77M	$481.72M	$117.20M
Total Liabilities	$14.00M	$11.87M	$9.39M
Cash & Equivalents	$101.58M	$325.89M	$25.83M
Free Cash Flow OCF − CapEx	$-133.44M	$-59.68M	$-38.07M
Shares Outstanding	54.24M	53.60M	2.99M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.